Authors: DALLEY D LEVI J BELL D GREEN M SHERMAN P ZALCBERG J ZIMET A THOMSON D WALPOLE E ACKLAND S STEWART J SCHULLER J FOGL U WIRTH M LUTZ D SALOMON J VANTRAPPEN G VANCUTSEM E LEPOUTRE L DEFACQ L BURY J REGINSTER M FROIMTCHUK M DEOLIVEIRA MDLL SCALETZKY A KOCHA W SKILLINGS J WEINERMAN B SHORE T MAROUN J CRIPPS C GOEL R BATIST G BOOS G GADEBERG C KJAER M BRUNSGAARD N JAKOBSEN A MEJLHOLM J BERTELSEN K MADSEN EL JORGENSEN A SANDBERG E PYRHONEN S ISOKANGAS OP JOHANSSON R KATAJA V ROUGIER P BECOUARN Y BRUNET R FRANCOIS E NAMER M SEITZ J GIOVANNINI H REBATTU P MERROUCHE Y LANKISCH P HEISE J MAY B GREVING J SODOMANN C BERGERMANN H MERTELSMANN R SCHUPP M PORZSOLT F STEINACKER RM CARTEI G BAJETTA E COLLEONI M PANNUTI E FOSSER V BERG C RAVN H EGELI R GUILLOU P SOMERS S CAREY P PRIMROSE J SELBY P WARD U BUDDE M HOLDENER EE MAN A MASSIMINI G SMITH H LUYKX R BLAES C YAP AKL HOLMSTROM S COCKEY L

Citation: D. Dalley et al., PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 921-928